{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:37:10Z","timestamp":1790095030494,"version":"4.0.1"},"reference-count":19,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>During the COVID-19 pandemic, a significant decline in Mycoplasma pneumoniae was observed; however, M. pneumoniae re-emerged globally in 2023. Here, we describe a current outbreak of M. pneumoniae infections in the United States (US). More than 287 million patient records from all 50 states in the US were reviewed to identify patients with a M. pneumoniae diagnosis between 1 January 2017 and 30 September 2024. A c-chart was created by calculating the mean and standard error (SE) of cases during the pre-COVID-19 pandemic period, with the upper control limit (UCL) set at 3 SE above the mean. The presence of an outbreak was defined as counts above the UCL. Cumulative excess cases were used to estimate the magnitude of the outbreak, and the fold increase was calculated. A US outbreak of M. pneumoniae began at the end of 2023, resulting in 9708 excess cases corresponding to a 9.0-fold increase over the baseline UCL. The outbreak is ongoing, affects both children and adults, and includes patients with M. pneumoniae community-acquired pneumonia requiring hospitalization. This US outbreak of M. pneumoniae has significant implications for the management of patients with respiratory infections during the current pneumonia season.<\/jats:p>","DOI":"10.3390\/pathogens14010060","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T07:40:08Z","timestamp":1736754008000},"page":"60","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Description of a Current Outbreak of Mycoplasma pneumoniae in the United States"],"prefix":"10.3390","volume":"14","author":[{"given":"Anupama","family":"Raghuram","sequence":"first","affiliation":[{"name":"Norton Infectious Diseases Institute, Norton Healthcare, Louisville, KY 40202, USA"},{"name":"Division of Infectious Diseases, University of Louisville, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9112-2860","authenticated-orcid":false,"given":"Stephen","family":"Furmanek","sequence":"additional","affiliation":[{"name":"Norton Infectious Diseases Institute, Norton Healthcare, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2284-6213","authenticated-orcid":false,"given":"Thomas","family":"Chandler","sequence":"additional","affiliation":[{"name":"Norton Infectious Diseases Institute, Norton Healthcare, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa","family":"Rashid","sequence":"additional","affiliation":[{"name":"Norton Infectious Diseases Institute, Norton Healthcare, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Mattingly","sequence":"additional","affiliation":[{"name":"Norton Infectious Diseases Institute, Norton Healthcare, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-5374","authenticated-orcid":false,"given":"Julio","family":"Ramirez","sequence":"additional","affiliation":[{"name":"Norton Infectious Diseases Institute, Norton Healthcare, Louisville, KY 40202, USA"},{"name":"Division of Infectious Diseases, University of Louisville, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults","volume":"373","author":"Jain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1023\/A:1007353121693","article-title":"A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946\u20131995","volume":"13","author":"Lind","year":"1997","journal-title":"Eur. J. Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1574-6976.2008.00129.x","article-title":"Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections","volume":"32","author":"Atkinson","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"You, J., Zhang, L., Chen, W., Wu, Q., Zhang, D., Luo, Z., and Fu, Z. (2024). Epidemiological characteristics of Mycoplasma pneumoniae in hospitalized children before, during, and after COVID-19 pandemic restrictions in Chongqing, China. Front. Cell Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1424554"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Boyanton, B.L., Frenner, R.A., Ingold, A., Ambroggio, L., and Kennedy, J.L. (2024). SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to Mycoplasma pneumoniae and co-infecting respiratory viruses in Arkansas. Microbiol. Spectr., 12.","DOI":"10.1128\/spectrum.02908-23"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lan, S., Gu, C., Lu, S., Zhou, N., and Qiao, X. (2024). Post-Pandemic Epidemiology of Respiratory Infections among Pediatric Inpatients in a Tertiary Hospital in Shanghai, China. Child, 11.","DOI":"10.3390\/children11091127"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3201\/eid3007.240315","article-title":"Large-Scale Outbreak of Mycoplasma pneumoniae Infection, Marseille, France, 2023\u20132024","volume":"30","author":"Edouard","year":"2024","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1017\/S0950268824000281","article-title":"Outbreak of Mycoplasma pneumoniae pneumonia in hospitalized patients: Who is concerned? Nord Franche-Comt\u00e9 Hospital, France, 2023\u20132024","volume":"152","author":"Zayet","year":"2024","journal-title":"Epidemiol. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmi.2024.05.005","article-title":"Unexpected increase of severe Mycoplasma pneumoniae pneumonia in adults in Southern Switzerland","volume":"30","author":"Garzoni","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15585\/mmwr.mm7307a3","article-title":"Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018\u20132024","volume":"73","author":"Edens","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_12","unstructured":"Centers for Disease Control and Prevention (2024, December 01). Mycoplasma pneumoniae Infection Surveillance and Trends, Available online: https:\/\/www.cdc.gov\/mycoplasma\/php\/surveillance\/index.html."},{"key":"ref_13","unstructured":"Epic Systems (2024, December 12). Epic Cosmos. Available online: https:\/\/cosmos.epic.com\/."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1055\/s-0041-1731004","article-title":"The Cosmos Collaborative: A Vendor-Facilitated Electronic Health Record Data Aggregation Platform","volume":"5","author":"Tarabichi","year":"2021","journal-title":"ACI Open"},{"key":"ref_15","unstructured":"National Institute of Standards and Technology (2024, December 01). NIST\/SEMATECH e-Handbook of Statistical Methods, Available online: http:\/\/www.itl.nist.gov\/div898\/handbook\/."},{"key":"ref_16","first-page":"2100746","article-title":"Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: Results of a global survey, 2017 to 2021","volume":"27","author":"Sauteur","year":"2022","journal-title":"Eurosurveillance"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","article-title":"Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: A prospective analysis of surveillance data","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Lancet Digit. Health"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Pereyre, S., Goret, J., and B\u00e9b\u00e9ar, C. (2016). Mycoplasma pneumoniae: Current knowledge on macrolide resistance and treatment. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00974"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Narita, M. (2016). Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00023"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/1\/60\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:27:04Z","timestamp":1759919224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/1\/60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["pathogens14010060"],"URL":"https:\/\/doi.org\/10.3390\/pathogens14010060","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]}}}